RBD protein vaccine

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRBD protein vaccine
Drug Alias NameSARS-CoV-2 RBD vaccine (Peter Doherty Institute for Infection and Immunity/Monash Institute of Pharmaceutical Sciences)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCopyright The Peter Doherty Institute For Infection And Immunity
China Registration ClassN/A

Develop Information

Active CompaniesMonash Institute of Pharmaceutical SciencesCopyright The Peter Doherty Institute For Infection And Immunity
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A